SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 7.17% in the revenue at Rs. 19280.00 millions was reported in the September 2022 quarter as compared to Rs. 17990.00 millions during year-ago period.The Company's Net profit for the September 2022 quarter have declined marginally to Rs. 2720.00  millions as against Rs. 3260.00 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 6310.00 millions from 6710.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 19280.00 17990.00 7.17 38610.00 34940.00 10.50 67420.00 64510.00 4.51
Other Income 110.00 540.00 -79.63 400.00 1040.00 -61.54 2040.00 1180.00 72.88
PBIDT 6310.00 6710.00 -5.96 13250.00 12990.00 2.00 23040.00 23100.00 -0.26
Interest 620.00 640.00 -3.13 1130.00 1300.00 -13.08 2360.00 3340.00 -29.34
PBDT 5690.00 6070.00 -6.26 12120.00 11690.00 3.68 20680.00 19760.00 4.66
Depreciation 1560.00 1530.00 1.96 3050.00 3030.00 0.66 6020.00 6100.00 -1.31
PBT 4130.00 4540.00 -9.03 9070.00 8660.00 4.73 14660.00 13660.00 7.32
TAX 1410.00 1280.00 10.16 3080.00 2660.00 15.79 4750.00 2280.00 108.33
Deferred Tax 710.00 490.00 44.90 1520.00 1150.00 32.17 2220.00 -200.00 -1210.00
PAT 2720.00 3260.00 -16.56 5990.00 6000.00 -0.17 9910.00 11380.00 -12.92
Equity 1692.30 846.20 99.99 1692.30 846.20 99.99 846.20 846.20 0.00
PBIDTM(%) 32.73 37.30 -12.25 34.32 37.18 -7.69 34.17 35.81 -4.56

Torrent Pharma Share Price

4178.85 22.50 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×